Care este prețul pentru Noxopharm Limited (NOX)

Prețul pentru Noxopharm Limited (NOX) este $0.0416118

Care este capitalizarea de piață pentru Noxopharm Limited (NOX)

Capitalizarea de piață pentru Noxopharm Limited (NOX) este $12.78M

Noxopharm Limited (NOX) Splituri de Acțiuni

Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate cancer and other solid tumors; LuPIN with combined therapy of Veyonda and 177Lu-PSMA-617 for the treatment of late-stage prostate cancer; IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types; and chemotherapy enhancement program (CEP) combined with carboplatin for patients with refractory solid tumors in the breast, head and neck, lung, prostate, and ovaries. In addition, it develops NOXCOVID Program, a dose escalation and dose expansion study of NOX66 for the treatment of COVID-19 infection. Further, the company develops programs to treat pancreatic cancer and glioblastoma. Noxopharm Limited has a collaboration with Hudson Institute of Medical Research and The Australian National University for the research and development of therapeutic drug against inflammatory disorders. The company was incorporated in 2015 and is based in Chatswood, Australia.

An	Split	Multiplu	Multiplu cumulativ
2020-05-19	283:250	x1.132	x1.132

Split

Multiplu

Multiplu cumulativ

2020-05-19

283:250

x1.132

Companie	Număr total de splituri	Multiplu cumulativ	Țara
Novo Nordisk A/S NVO.US	5	x199	DK
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Regeneron Pharmaceuticals, Inc. REGN.US	0	-	US
UCB SA UCB.BR	0	-	BE
CSL Limited CSL.AX	1	x3	AU

Companie

Număr total de splituri

Multiplu cumulativ

Țara